Literature DB >> 12775618

Characteristics of general practitioners who frequently see drug industry representatives: national cross sectional study.

Chris Watkins1, Laurence Moore, Ian Harvey, Patricia Carthy, Elizabeth Robinson, Richard Brawn.   

Abstract

Keywords:  Empirical Approach; Health Care and Public Health

Mesh：

Year:  2003        PMID： 12775618      PMCID： PMC156455          DOI： 10.1136/bmj.326.7400.1178

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicalising effect of prescribing antibiotics.

Authors:  P Little; C Gould; I Williamson; G Warner; M Gantley; A L Kinmonth
Journal:  BMJ       Date:  1997-08-09

2.  Low income scheme index: a new deprivation scale based on prescribing in general practice.

Authors:  D C Lloyd; C M Harris; D W Clucas
Journal:  BMJ       Date:  1995-01-21

3.  Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey.

Authors:  C Watkins; I Harvey; P Carthy; L Moore; E Robinson; R Brawn
Journal:  Qual Saf Health Care       Date:  2003-02
  3 in total
  21 in total

1.  [The regulation of medical visits: necessary but insufficient].

Authors:  R Madridejos Mora
Journal:  Aten Primaria       Date:  2003-12       Impact factor: 1.137

2.  No more free lunches.

Authors:  Kamran Abbasi; Richard Smith
Journal:  BMJ       Date:  2003-05-31

3.  Prevalence and determinants of physician participation in conducting pharmaceutical-sponsored clinical trials and lectures.

Authors:  Bimal H Ashar; Redonda G Miller; Kelly J Getz; Neil R Powe
Journal:  J Gen Intern Med       Date:  2004-11       Impact factor: 5.128

4.  Interactions of doctors with the pharmaceutical industry.

Authors:  M A Morgan; J Dana; G Loewenstein; S Zinberg; J Schulkin
Journal:  J Med Ethics       Date:  2006-10       Impact factor: 2.903

5.  Physicians, social media, and conflict of interest.

Authors:  Matthew Decamp
Journal:  J Gen Intern Med       Date:  2012-11-06       Impact factor: 5.128

6.  Direct-to-consumer and physician promotion of tegaserod correlated with physician visits, diagnoses, and prescriptions.

Authors:  Spencer D Dorn; Joel F Farley; Richard A Hansen; Nilay D Shah; Robert S Sandler
Journal:  Gastroenterology       Date:  2009-05-13       Impact factor: 22.682

7.  Japanese practicing physicians' relationships with pharmaceutical representatives: a national survey.

Authors:  Sayaka Saito; Kei Mukohara; Seiji Bito
Journal:  PLoS One       Date:  2010-08-13       Impact factor: 3.240

8.  Risk factors for potentially inappropriate prescribing to older patients in primary care.

Authors:  Ivana Projovic; Dubravka Vukadinovic; Olivera Milovanovic; Milena Jurisevic; Radisa Pavlovic; Sasa Jacovic; Slobodan Jankovic; Srdjan Stefanovic
Journal:  Eur J Clin Pharmacol       Date:  2015-09-29       Impact factor: 2.953

9.  Influence of Pharmaceutical Company Engagement Activities on the Decision to Prescribe: A Pilot Survey of UK Rare Disease Medicine Prescribers.

Authors:  Ravi Jandhyala
Journal:  Pharmaceut Med       Date:  2020-04

10.  A survey of pharmaceutical company representative interactions with doctors in Libya.

Authors:  Mustafa A Alssageer; Stefan R Kowalski
Journal:  Libyan J Med       Date:  2012-09-18       Impact factor: 1.657
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.